Search research articles
Contact Us
Filters
Showing results (241-250 of 287) with videos related to
Page
of 29
Sort By:
Leukemia & Lymphoma
|
December 4, 2020
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria
Leslie K Ballas, Monika L Metzger, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2024
Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma
Robert W Gao, Ralph F Fleuranvil, William S Harmsen, et al.
American Journal of Clinical Oncology
|
June 15, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II
Kenneth B Roberts, Anas Younes, David C Hodgson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy
Bradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.
American Journal of Clinical Oncology
|
September 20, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II
Sughosh Dhakal, Ranjana Advani, Leslie K Ballas, et al.
Journal of the American College of Radiology : JACR
|
October 4, 2014
ACR appropriateness criteria follow-up of Hodgkin lymphoma
Chul S Ha, David C Hodgson, Ranjana Advani, et al.
American Journal of Clinical Oncology
|
November 20, 2015
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma
Bouthaina S Dabaja, Ranjana Advani, David C Hodgson, et al.
International Journal of Particle Therapy
|
November 1, 2021
Consensus Statement on Proton Therapy for Prostate Cancer
Curtis M Bryant, Randal H Henderson, R Charles Nichols, et al.
Advances in Radiation Oncology
|
December 11, 2025
Reduced-Dose Hypofractionated Radiation Therapy (3 Gy × 3 Fractions) for Indolent Non-Hodgkin's lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial Protocol
Omran Saifi, Scott C Lester, William G Rule, et al.
Nature Biotechnology
|
July 13, 2016
Software tools for single-cell tracking and quantification of cellular and molecular properties
Oliver Hilsenbeck, Michael Schwarzfischer, Stavroula Skylaki, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 287) with videos related to
Sort By:
Page
of 29
Leukemia & Lymphoma
|
December 4, 2020
Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria
Leslie K Ballas, Monika L Metzger, Sarah A Milgrom, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 30, 2024
Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma
Robert W Gao, Ralph F Fleuranvil, William S Harmsen, et al.
American Journal of Clinical Oncology
|
June 15, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II
Kenneth B Roberts, Anas Younes, David C Hodgson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 3, 2023
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy
Bradford S Hoppe, Kathleen M McCarten, Qinglin Pei, et al.
American Journal of Clinical Oncology
|
September 20, 2016
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II
Sughosh Dhakal, Ranjana Advani, Leslie K Ballas, et al.
Journal of the American College of Radiology : JACR
|
October 4, 2014
ACR appropriateness criteria follow-up of Hodgkin lymphoma
Chul S Ha, David C Hodgson, Ranjana Advani, et al.
American Journal of Clinical Oncology
|
November 20, 2015
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma
Bouthaina S Dabaja, Ranjana Advani, David C Hodgson, et al.
International Journal of Particle Therapy
|
November 1, 2021
Consensus Statement on Proton Therapy for Prostate Cancer
Curtis M Bryant, Randal H Henderson, R Charles Nichols, et al.
Advances in Radiation Oncology
|
December 11, 2025
Reduced-Dose Hypofractionated Radiation Therapy (3 Gy × 3 Fractions) for Indolent Non-Hodgkin's lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial Protocol
Omran Saifi, Scott C Lester, William G Rule, et al.
Nature Biotechnology
|
July 13, 2016
Software tools for single-cell tracking and quantification of cellular and molecular properties
Oliver Hilsenbeck, Michael Schwarzfischer, Stavroula Skylaki, et al.
Page
of 29